| Product Code: ETC10223273 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Suriname continued to import prostate-specific antigen blood-based biomarkers primarily from the United States of America, Netherlands, Brazil, United Kingdom, and India. Despite a significant decline in the Compound Annual Growth Rate (CAGR) from 2020-24 at -26.83%, the market remained concentrated with a high Herfindahl-Hirschman Index (HHI). The drastic growth rate decrease of -67.36% from 2023-24 indicates a challenging year for imports in this sector. Keep an eye on evolving trends and market dynamics to anticipate future developments in the Suriname biomarker import market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2022 & 2032F |
3.8 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2022 & 2032F |
3.9 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2022 & 2032F |
4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in Suriname |
4.2.2 Growing awareness about the importance of early detection and screening for prostate cancer |
4.2.3 Technological advancements in the development of prostate-specific antigen blood-based biomarkers |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities for screening and diagnostic services in remote areas of Suriname |
4.3.2 Lack of skilled healthcare professionals for efficient diagnosis and management of prostate cancer in Suriname |
5 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2022 - 2032F |
6.1.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2022 - 2032F |
6.1.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2022 - 2032F |
6.1.5 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2022 - 2032F |
6.1.6 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2022 - 2032F |
6.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2022 - 2032F |
6.2.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2022 - 2032F |
6.2.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2022 - 2032F |
6.2.5 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2022 - 2032F |
6.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2022 - 2032F |
6.3.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2022 - 2032F |
6.3.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2022 - 2032F |
6.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2022 - 2032F |
6.5 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2022 - 2032F |
6.5.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.5.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2022 - 2032F |
7 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Average age of patients diagnosed with prostate cancer in Suriname |
8.2 Number of prostate cancer screening campaigns conducted annually in Suriname |
8.3 Adoption rate of prostate-specific antigen blood-based biomarker tests in Suriname |
9 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2022 & 2032F |
9.3 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2022 & 2032F |
9.4 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2022 & 2032F |
9.5 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2022 & 2032F |
10 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2025 |
10.2 Suriname Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here